![Lyhen González Lio](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Relations actives
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Juan Camacho | M | - |
Palobiofarma SL
![]() Palobiofarma SL Pharmaceuticals: MajorHealth Technology Palo Biofarma SL discovers and develops pharmaceutical products. Its pipeline consists of receptors which target pulmonary diseases, attention-deficit disorders, glaucoma, and degenerative conditions. The company was founded by Juan Camacho Gamez in 2006 and is headquartered in Noáin, Spain. | 21 ans |
Josep María Echarri Torres | M | 48 |
Palobiofarma SL
![]() Palobiofarma SL Pharmaceuticals: MajorHealth Technology Palo Biofarma SL discovers and develops pharmaceutical products. Its pipeline consists of receptors which target pulmonary diseases, attention-deficit disorders, glaucoma, and degenerative conditions. The company was founded by Juan Camacho Gamez in 2006 and is headquartered in Noáin, Spain. | 14 ans |
Carlos Alberto Garrido Arribas | M | - |
Palobiofarma SL
![]() Palobiofarma SL Pharmaceuticals: MajorHealth Technology Palo Biofarma SL discovers and develops pharmaceutical products. Its pipeline consists of receptors which target pulmonary diseases, attention-deficit disorders, glaucoma, and degenerative conditions. The company was founded by Juan Camacho Gamez in 2006 and is headquartered in Noáin, Spain. | - |
María Eugenia Lecumberri Alli | F | 59 |
Palobiofarma SL
![]() Palobiofarma SL Pharmaceuticals: MajorHealth Technology Palo Biofarma SL discovers and develops pharmaceutical products. Its pipeline consists of receptors which target pulmonary diseases, attention-deficit disorders, glaucoma, and degenerative conditions. The company was founded by Juan Camacho Gamez in 2006 and is headquartered in Noáin, Spain. | - |
Jesús Javier Cía Barrio | M | - |
Palobiofarma SL
![]() Palobiofarma SL Pharmaceuticals: MajorHealth Technology Palo Biofarma SL discovers and develops pharmaceutical products. Its pipeline consists of receptors which target pulmonary diseases, attention-deficit disorders, glaucoma, and degenerative conditions. The company was founded by Juan Camacho Gamez in 2006 and is headquartered in Noáin, Spain. | - |
Don Santiago de Torres Sanahuja | M | - |
Palobiofarma SL
![]() Palobiofarma SL Pharmaceuticals: MajorHealth Technology Palo Biofarma SL discovers and develops pharmaceutical products. Its pipeline consists of receptors which target pulmonary diseases, attention-deficit disorders, glaucoma, and degenerative conditions. The company was founded by Juan Camacho Gamez in 2006 and is headquartered in Noáin, Spain. | - |
Alely Gessa Abreu | F | - |
Palobiofarma SL
![]() Palobiofarma SL Pharmaceuticals: MajorHealth Technology Palo Biofarma SL discovers and develops pharmaceutical products. Its pipeline consists of receptors which target pulmonary diseases, attention-deficit disorders, glaucoma, and degenerative conditions. The company was founded by Juan Camacho Gamez in 2006 and is headquartered in Noáin, Spain. | - |
Nahomi Castro-Palomino Laria | F | - |
Palobiofarma SL
![]() Palobiofarma SL Pharmaceuticals: MajorHealth Technology Palo Biofarma SL discovers and develops pharmaceutical products. Its pipeline consists of receptors which target pulmonary diseases, attention-deficit disorders, glaucoma, and degenerative conditions. The company was founded by Juan Camacho Gamez in 2006 and is headquartered in Noáin, Spain. | - |
Jaume Busquets Viñallonga | M | - |
Palobiofarma SL
![]() Palobiofarma SL Pharmaceuticals: MajorHealth Technology Palo Biofarma SL discovers and develops pharmaceutical products. Its pipeline consists of receptors which target pulmonary diseases, attention-deficit disorders, glaucoma, and degenerative conditions. The company was founded by Juan Camacho Gamez in 2006 and is headquartered in Noáin, Spain. | - |
Julio Cesar Castro-Palomino | M | - |
Palobiofarma SL
![]() Palobiofarma SL Pharmaceuticals: MajorHealth Technology Palo Biofarma SL discovers and develops pharmaceutical products. Its pipeline consists of receptors which target pulmonary diseases, attention-deficit disorders, glaucoma, and degenerative conditions. The company was founded by Juan Camacho Gamez in 2006 and is headquartered in Noáin, Spain. | - |
Graphique Relationnel
Relation dans plusieurs entreprises
Statistiques
Pays | Relations | % du total |
---|---|---|
Espagne | 10 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Lyhen González Lio
- Réseau Personnel